Odontoprev (ODPV3) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Celebrated the launch of the SAUD3 ticker and Bradsaúde's entry into B3, marking a new chapter in the company's evolution and completion of the merger between Bradesco Saúde, Odontoprev, and related assets.
The ecosystem integrates health and dental insurance, hospitals, clinics, diagnostics, and technology, serving over 13 million beneficiaries nationwide.
Achieved revenues of R$13.4 billion in 1Q26, with net income of R$1.3 billion and a total of 13.4 million members, reflecting strong growth and scale in the healthcare ecosystem.
Major corporate restructuring completed, merging Bradesco Saúde, Odontoprev, and other assets under Bradsaúde.
Net additions of 193,000 beneficiaries in the quarter and 710,000 over the past 12 months, driven by commercial synergies and service expansion.
Financial highlights
Revenues reached R$13.4 billion in 1Q26, with net income of R$1.3 billion and financial assets totaling R$28.6 billion.
Bradesco Saúde posted net income of R$914 million in 1Q26, while Odontoprev net income was R$150.6 million.
Written premiums for 1Q26 were R$13.3 billion, up 8.4% year-over-year; Odontoprev net revenue reached R$2.4 billion in MAR26.
Financial results of R$875 million in 1Q26, with no debt.
Atlântica Hospitais manages 3,921 beds, with R$4.8 billion committed and R$2.8 billion already deployed in hospital investments.
Outlook and guidance
Management remains cautious about claims ratio trends for 2026, citing seasonality, rising frequency, and costs.
Continued expansion of hospital network with new openings scheduled through 2029, including Santa Lúcia Gama and Albert Einstein Vila Mariana.
Ongoing investments in technology, digital health, and innovation to enhance customer experience and operational efficiency.
Focus on sustainable growth, balancing member additions with margin and claims management.
Plans to maintain strict capital allocation discipline, with updates on dividend proposals forthcoming.
Latest events from Odontoprev
- Membership and revenue growth fueled margin expansion and strong cash generation in 2025.ODPV3
Q4 20258 Apr 2026 - Record net income, margin expansion, and SME/Individual growth with strong cash position.ODPV3
Q3 20243 Feb 2026 - Record profitability, margin expansion, and 100% net income payout in 2Q24.ODPV3
Q2 20242 Feb 2026 - High-margin, tech-focused dental insurer grows SME segment, sustains top dividends, and zero debt.ODPV3
Status update28 Jan 2026 - Record recurring net income, margin expansion, and high payouts marked a strong 2024.ODPV3
Q4 20246 Jan 2026 - Record SME and Individual plan growth, margin expansion, and strong cash generation.ODPV3
Q2 202523 Nov 2025 - EBITDA margin rose to 38.3% in Q1 2025, led by SME and individual segment growth.ODPV3
Q1 202519 Nov 2025 - Record SME and Individual plan growth drove revenue, margin, and shareholder return gains.ODPV3
Q3 202513 Nov 2025